Antimicrobial susceptibility of Salmonella enterica serovars in a tertiary care hospital in southern India
- PMID: 23703350
- PMCID: PMC3724263
Antimicrobial susceptibility of Salmonella enterica serovars in a tertiary care hospital in southern India
Abstract
Background & objectives: Salmonella enterica serovars Typhi and Paratyphi are predominantly known to cause enteric fever. Multidrug resistance in S. Tphi and S. Paratyphi has emerged as a cause of concern. This study was done to evaluate status in antimicrobial susceptibility patterns of Salmonella enterica serovar Typhi (S. Typhi) and S. Paratyphi obtained from blood culture in a tertiary care hospital in south India.
Methods: Blood isolates of Salmonella species over a two year period between May 2009 and June 2011 were studied. A total of 322 isolates of Salmonella species were tested for antimicrobial susceptibility by Kirby-Bauer disc diffusion method. The MIC of ciprofloxacin was obtained by E-test, and azithromycin MIC was confirmed by agar dilution method for a limited number of isolates.
Results: Of the total of 322 isolates studied, 186 (57.8%) were S. Typhi, 134 (41.6%) were S. Paratyphi A, and two were S. Paratyphi B. Of these, 44(13.66%) were resistant to ciprofloxacin (MIC <0.50 μg/ml) and 296 (91.9%) were nalidixic acid resistant. Of these 296 nalidixic acid resistant isolates, 278 (94%) were susceptible to ciprofloxacin by MIC criteria (<0.5 μg/ml). Of the 262 isolates tested for azithromycin sensitivity, only 120 (46%) were susceptible, whereas 81 (31%) were resistant and 55 (21%) showed intermediate susceptibility. Of the isolates, 322 (90%) were susceptible to ampicillin and (95%) were susceptible to co-trimoxazole. However, all the isolates were susceptible to chloramphenicol and ceftriaxone.
Interpretation & conclusions: Nalidixic acid resistance screening is not a reliable surrogate indicator of ciprofloxacin resistance. Ciprofloxacin MIC should to be routinely done. Azithromycin resistance appears to be emerging. However, isolates showed a high degree of susceptibility to ampicillin, co-trimoxazole and chloramphenicol. Thus, antibiotics like ampicillin and co-trimoxazole may once again be useful for the management of enteric fever in southern India.
Similar articles
-
Absence of multidrug resistance in Salmonella enterica serotypes Typhi and Paratyphi A isolates with intermediate susceptibility to ciprofloxacin.Trans R Soc Trop Med Hyg. 2015 Aug;109(8):538-40. doi: 10.1093/trstmh/trv036. Epub 2015 May 15. Trans R Soc Trop Med Hyg. 2015. PMID: 25979527
-
Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and Paratyphi A isolates with decreased susceptibility to ciprofloxacin.Trans R Soc Trop Med Hyg. 2016 Aug;110(8):472-9. doi: 10.1093/trstmh/trw051. Epub 2016 Sep 12. Trans R Soc Trop Med Hyg. 2016. PMID: 27618918
-
Treatment of enteric fever in children on the basis of current trends of antimicrobial susceptibility of Salmonella enterica serovar typhi and paratyphi A.Indian J Med Microbiol. 2006 Apr;24(2):101-6. doi: 10.4103/0255-0857.25182. Indian J Med Microbiol. 2006. PMID: 16687859
-
Antimicrobial resistance in Salmonella enterica serovar typhi and paratyphi in South Asia-current status, issues and prospects.Crit Rev Microbiol. 2015;41(4):536-45. doi: 10.3109/1040841X.2014.880662. Epub 2014 Mar 19. Crit Rev Microbiol. 2015. PMID: 24645636 Review.
-
A case report and review of the literature: ciprofloxacin resistant Salmonella enterica serovar Typhi in India.J Infect Dev Ctries. 2008 Aug 30;2(4):324-7. doi: 10.3855/jidc.229. J Infect Dev Ctries. 2008. PMID: 19741296 Review.
Cited by
-
Ampicillin: rise fall and resurgence.J Clin Diagn Res. 2014 May;8(5):ME01-3. doi: 10.7860/JCDR/2014/8777.4356. Epub 2014 May 15. J Clin Diagn Res. 2014. PMID: 24995206 Free PMC article. Review.
-
Salmonella enterica Serovar Typhi in Bangladesh: Exploration of Genomic Diversity and Antimicrobial Resistance.mBio. 2018 Nov 13;9(6):e02112-18. doi: 10.1128/mBio.02112-18. mBio. 2018. PMID: 30425150 Free PMC article.
-
Longitudinal Typhoid Fever Trends in India from 2000 to 2015.Am J Trop Med Hyg. 2018 Sep;99(3_Suppl):34-40. doi: 10.4269/ajtmh.18-0139. Epub 2018 Jul 24. Am J Trop Med Hyg. 2018. PMID: 30047367 Free PMC article.
-
Myositis associated with Salmonella paratyphi A bacteremia appears to be common.J Family Med Prim Care. 2019 Jan;8(1):125-129. doi: 10.4103/jfmpc.jfmpc_202_18. J Family Med Prim Care. 2019. PMID: 30911492 Free PMC article.
-
Genomic profiling of antimicrobial resistance genes in clinical isolates of Salmonella Typhi from patients infected with Typhoid fever in India.Sci Rep. 2020 May 19;10(1):8299. doi: 10.1038/s41598-020-64934-0. Sci Rep. 2020. PMID: 32427945 Free PMC article.
References
-
- Madhulika U, Harish BN, Parija SC. Current pattern in antimicrobial susceptibility of Salmonella Typhi isolates in Pondicherry. Indian J Med Res. 2004;120:111–4. - PubMed
-
- Brown JC, Shanahan PM, Jesudason MV, Thomson CJ, Amyes SG. Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multi-resistant Salmonella Typhi in India. J Antimicrob Chemother. 1996;37:891–900. - PubMed
-
- Effa EE, Bukirwa H. Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever) Cochrane Database Syst Rev. 2008;(4):CD006083. - PubMed
-
- Menezes GA, Harish BN, Khan MA, Goessens WH, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009. Clin Microbiol Infect. 2012;18:239–45. - PubMed
-
- Harish BN, Menezes GA. Preserving efficacy of chloramphenicol against typhoid fever in a tertiary care hospital, India. Reg Health Forum. 2011;15:92–6.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources